Treatment of intracranial metastatic esthesioneuroblastoma

A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.

Neuro-oncology advances·2022

Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.

Neuro-oncology·2018

Leptomeningeal metastasis.

Handbook of clinical neurology·2018

Cerebrospinal Fluid Dissemination and Neoplastic Meningitis in Primary Brain Tumors.

Cancer control : journal of the Moffitt Cancer Center·2017

Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.

Journal of neuro-oncology·2017

Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee.

Neuro-oncology·2017

First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

When Survival Separates.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Transcriptomic Plasticity and Its Spatial Architecture Shape Melanoma Response to Immunotherapy and Its Combination With BRAF/MEKi.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Patient-Level Evaluation of Optimal Margin Width for Lumpectomy in Ductal Carcinoma In Situ: An Analysis of Patients in the National Cancer Database Special Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Association Between Patient-Reported Outcomes and Health Care Resource Utilization: Toward Developing Patient-Centered Value Measures in Cancer Care.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.

Cancer discovery·2026

Clinical and scintigraphic improvement of mandibular involvement associated with chronic nonbacterial osteitis following an interleukin-23 inhibitor: a case-based literature review.

Immunological medicine·2026

Navigating clozapine discontinuation in clinical practice: An updated framework.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026

Early progression after immune checkpoint inhibitor therapy in recurrent or metastatic head and neck squamous cell carcinoma: association with disease distribution in a single-center retrospective study.

Japanese journal of clinical oncology·2026

Evaluation of the protective effects of green tea for ischemia-reperfusion injury in rat ovary tissue: an experimental study.

Acta cirurgica brasileira·2026

Early intervention with clozapine: Is there a neurobiological critical period for treatment-resistant schizophrenia?

Journal of psychopharmacology (Oxford, England)·2026

Related Experiment Videos

Treatment of intracranial metastatic esthesioneuroblastoma

Related Concept Videos

A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.

Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.

Leptomeningeal metastasis.

Cerebrospinal Fluid Dissemination and Neoplastic Meningitis in Primary Brain Tumors.

Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.

Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee.

First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT).

Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer.

When Survival Separates.

Transcriptomic Plasticity and Its Spatial Architecture Shape Melanoma Response to Immunotherapy and Its Combination With BRAF/MEKi.

Patient-Level Evaluation of Optimal Margin Width for Lumpectomy in Ductal Carcinoma In Situ: An Analysis of Patients in the National Cancer Database Special Study.

Association Between Patient-Reported Outcomes and Health Care Resource Utilization: Toward Developing Patient-Centered Value Measures in Cancer Care.

Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.

Clinical and scintigraphic improvement of mandibular involvement associated with chronic nonbacterial osteitis following an interleukin-23 inhibitor: a case-based literature review.

Navigating clozapine discontinuation in clinical practice: An updated framework.

Early progression after immune checkpoint inhibitor therapy in recurrent or metastatic head and neck squamous cell carcinoma: association with disease distribution in a single-center retrospective study.

Evaluation of the protective effects of green tea for ischemia-reperfusion injury in rat ovary tissue: an experimental study.

Early intervention with clozapine: Is there a neurobiological critical period for treatment-resistant schizophrenia?

Related Experiment Videos

Treatment of intracranial metastatic esthesioneuroblastoma

Related Concept Videos

Related Articles